Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Express Scripts
Moodys
Merck
Baxter

Last Updated: January 22, 2020

DrugPatentWatch Database Preview

Casper Pharma Llc Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for CASPER PHARMA LLC, and what generic and branded alternatives to CASPER PHARMA LLC drugs are available?

CASPER PHARMA LLC has fourteen approved drugs.



Summary for Casper Pharma Llc
US Patents:0
Tradenames:15
Ingredients:14
NDAs:14

Drugs and US Patents for Casper Pharma Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Casper Pharma Llc ZYLOPRIM allopurinol TABLET;ORAL 016084-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial
Casper Pharma Llc ROBINUL glycopyrrolate TABLET;ORAL 012827-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial
Casper Pharma Llc THALITONE chlorthalidone TABLET;ORAL 019574-002 Feb 12, 1992 DISCN No No   Start Trial   Start Trial
Casper Pharma Llc ANTIVERT meclizine hydrochloride TABLET, CHEWABLE;ORAL 010721-005 Approved Prior to Jan 1, 1982 AA RX Yes No   Start Trial   Start Trial
Casper Pharma Llc NEOSPORIN bacitracin zinc; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 050417-001 Approved Prior to Jan 1, 1982 AT RX Yes No   Start Trial   Start Trial
Casper Pharma Llc PERMAPEN penicillin g benzathine INJECTABLE;INJECTION 060014-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Casper Pharma Llc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Casper Pharma Llc THALITONE chlorthalidone TABLET;ORAL 019574-001 Dec 20, 1988 4,933,360   Start Trial
Casper Pharma Llc ZYLOPRIM allopurinol TABLET;ORAL 016084-001 Approved Prior to Jan 1, 1982 3,624,205   Start Trial
Casper Pharma Llc ZYLOPRIM allopurinol TABLET;ORAL 016084-002 Approved Prior to Jan 1, 1982 3,624,205   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for CASPER PHARMA LLC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 1 mg ➤ Subscribe 2009-08-14
➤ Subscribe Tablets 2 mg ➤ Subscribe 2010-10-12
➤ Subscribe Tablets 1.5 mg ➤ Subscribe 2009-05-06
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Mallinckrodt
McKesson
AstraZeneca
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.